Found: 8
Select item for more details and to access through your institution.
L-4F Inhibits Lipopolysaccharide-Mediated Activation of Primary Human Neutrophils.
- Published in:
- Inflammation, 2014, v. 37, n. 5, p. 1401, doi. 10.1007/s10753-014-9864-7
- By:
- Publication type:
- Article
HDL therapy for cardiovascular diseases: the road to HDL mimetics.
- Published in:
- Current Atherosclerosis Reports, 2008, v. 10, n. 5, p. 405, doi. 10.1007/s11883-008-0063-6
- By:
- Publication type:
- Article
Bioenergetic programming of macrophages by the apolipoprotein A-I mimetic peptide 4F.
- Published in:
- Biochemical Journal, 2015, v. 467, n. 3, p. 517, doi. 10.1042/BJ20131635
- By:
- Publication type:
- Article
Comparison of anti-endotoxin activity of apoE and apoA mimetic derivatives of a model amphipathic peptide 18A.
- Published in:
- Innate Immunity, 2014, v. 20, n. 8, p. 867, doi. 10.1177/1753425913514621
- By:
- Publication type:
- Article
Mechanism(s) of an apolipoprotein mimetic peptide in inhibitng amyloid plaque deposition- results from in vivo and in vitro studies
- Published in:
- 2010
- By:
- Publication type:
- Abstract
P2-299: Oral administration of an apolipoprotein A-I–mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer disease
- Published in:
- 2008
- By:
- Publication type:
- Abstract
Anti-Inflammatory Mechanisms of Apolipoprotein A-I Mimetic Peptide in Acute Respiratory Distress Syndrome Secondary to Sepsis
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0064486
- By:
- Publication type:
- Article
Apolipoprotein A-I mimetics mitigate intestinal inflammation in COX2-dependent inflammatory bowel disease model.
- Published in:
- 2019
- By:
- Publication type:
- journal article